BeStock  
Stocks › Biotechnology › FDMT

4D Molecular Therapeutics FDMT

US equityMarket cap rank #3514Biotechnology
$12.59 +$0.03 (+0.24%)
Pre-market · Oct 8, 8:10 am ET · After hours $12.59 0.00%
Open$12.36
Prev close$12.56
Day range$12.19 – $12.92
Volume603.6K
Market cap$695.52M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$30.43+141.7% vs. price
  • Buy 89%
  • Hold 11%
Low $23.00Now $12.59Avg $30.43High $36.00

Recent rating changes

The last 20 actions on file set price targets from $23.00 to $36.00, averaging $31.29.

DateFirmRatingTarget
6 Oct 2026 Chardan Capital BUY $25.00
28 Sep 2026 BofA Securities BUY $33.00
28 Sep 2026 Morgan Stanley HOLD –
21 Sep 2026 Cantor Fitzgerald BUY –
11 Sep 2026 Barclays BUY $28.00
17 Aug 2026 Morgan Stanley HOLD –
14 Aug 2026 BofA Securities BUY –
14 Aug 2026 Morgan Stanley HOLD –
14 Aug 2026 H.C. Wainwright BUY $36.00
14 Aug 2026 RBC Capital BUY $35.00
20 Jul 2026 BofA Securities BUY $29.00
20 Jul 2026 Evercore BUY $23.00
20 Jul 2026 Goldman Sachs BUY $33.00
20 Jul 2026 H.C. Wainwright BUY $36.00
30 Jun 2026 H.C. Wainwright BUY $36.00
29 Jun 2026 Morgan Stanley HOLD –
11 May 2026 H.C. Wainwright BUY $36.00
8 May 2026 Chardan Capital BUY $26.00
8 May 2026 BofA Securities BUY $29.00
8 May 2026 Goldman Sachs BUY $33.00

Discussion

No comments yet — be the first to weigh in on FDMT.

Leave a comment

Scroll to Top